Bioactive SiO2-CaO-P2O5 hollow nanospheres for drug delivery

被引:15
作者
Li, Bin [1 ]
Luo, Wenqin [2 ]
Wang, Yongya [2 ]
Wu, Haiyan [1 ]
Zhang, Chengcheng [2 ]
机构
[1] Huzhou Univ, Sch Life Sci, Huzhou 313000, Zhejiang, Peoples R China
[2] Huzhou Univ, Sch Engn, Huzhou 313000, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
Bioactive glass; Drug delivery; Hollow nanospheres; GLASS NANOPARTICLES; SPHERES; PARTICLES;
D O I
10.1016/j.jnoncrysol.2016.05.041
中图分类号
TQ174 [陶瓷工业]; TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Hollow nanospherical bioactive glasses have attracted much interest in the recent years because of their important applications in drug delivery and hard tissue repair. Herein, we developed a facile method to fabricate bioactive SiO2-CaO-P2O5 (SCP) hollow nanospheres using polystyrene (PS) nanospheres as the hard template. The removal of PS templates by heating produced almost monodispersed hollow SCP nanospheres with an inner cavity of 210 nm, making them suitable for drug delivery. The impact of the glass composition on the formation of hollow SCP nanospheres was investigated in detail. High drug-loading capacity and sustained multistep release of theophylline in the SCP nanospheres were achieved. Furthermore, the SCP nanospheres exhibited apatite forming ability when immersed in a simulated body fluid. Cytotoxicity of SCP nanospheres on live cells has been evaluated. The SCP hollow nanospheres with sustained drug release property and bioactivity are promising new-generation biomaterials. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:98 / 103
页数:6
相关论文
共 25 条
  • [1] On a theory of the van der Waals adsorption of gases
    Brunauer, S
    Deming, LS
    Deming, WE
    Teller, E
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1940, 62 : 1723 - 1732
  • [2] Facile size-controllable syntheses of highly monodisperse polystyrene nano- and microspheres by polyvinylpyrrolidone-mediated emulsifier-free emulsion polymerization
    Du, Xin
    He, Junhui
    [J]. JOURNAL OF APPLIED POLYMER SCIENCE, 2008, 108 (03) : 1755 - 1760
  • [3] Capacity of mesoporous bioactive glass nanoparticles to deliver therapeutic molecules
    El-Fiqi, Ahmed
    Kim, Tae-Hyun
    Kim, Meeju
    Eltohamy, Mohamed
    Won, Jong-Eun
    Lee, Eun-Jung
    Kim, Hae-Won
    [J]. NANOSCALE, 2012, 4 (23) : 7475 - 7488
  • [4] Bioactive materials for biomedical applications using sol-gel technology
    Gupta, Radha
    Kumar, Ashok
    [J]. BIOMEDICAL MATERIALS, 2008, 3 (03)
  • [5] Hybrid Mesoporous Silica-Based Drug Carrier Nanostructures with Improved Degradability by Hydroxyapatite
    Hao, Xiaohong
    Hu, Xixue
    Zhang, Cuimiao
    Chen, Shizhu
    Li, Zhenhua
    Yang, Xinjian
    Liu, Huifang
    Jia, Guang
    Liu, Dandan
    Ge, Kun
    Liang, Xing-Jie
    Zhang, Jinchao
    [J]. ACS NANO, 2015, 9 (10) : 9614 - 9625
  • [6] Fabrication and Drug Delivery of Ultrathin Mesoporous Bioactive Glass Hollow Fibers
    Hong, Youliang
    Chen, Xuesi
    Jing, Xiabin
    Fan, Hongsong
    Gu, Zhongwei
    Zhang, Xingdong
    [J]. ADVANCED FUNCTIONAL MATERIALS, 2010, 20 (09) : 1503 - 1510
  • [7] Size control and biological properties of monodispersed mesoporous bioactive glass submicron spheres
    Hu, Qing
    Li, Yuli
    Miao, Guohou
    Zhao, Naru
    Chen, Xiaofeng
    [J]. RSC ADVANCES, 2014, 4 (43): : 22678 - 22687
  • [8] Review of bioactive glass: From Hench to hybrids
    Jones, Julian R.
    [J]. ACTA BIOMATERIALIA, 2013, 9 (01) : 4457 - 4486
  • [9] Production and potential of bioactive glass nanofibers as a next-generation biomaterial
    Kim, Hae-Won
    Kim, Hyoun-Ee
    Knowles, Jonathan C.
    [J]. ADVANCED FUNCTIONAL MATERIALS, 2006, 16 (12) : 1529 - 1535
  • [10] How useful is SBF in predicting in vivo bone bioactivity?
    Kokubo, T
    Takadama, H
    [J]. BIOMATERIALS, 2006, 27 (15) : 2907 - 2915